Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of SAR342434 vs Humalog in Type 1 Diabetes
NCT02273258Phase 1Completed
- Sponsor
- Sanofi
- Start
- Mar 2013
- Primary completion
- Jul 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro (Wockhardt) in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Sanofi. Primary endpoints: Maximum Plasma Concentration at 12 hours, Area Under the Concentration-Time Curve at 12 hours and 1 more. Started Mar 2013; status: completed.
02
Drugs
insulin lispro (Wockhardt)
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02273258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273258.